Transcriptomics Industry Research Report 2023

Transcriptomics Industry Research Report 2023


Transcriptomic incorporates the exploration and assortment of transcriptomes and finds diverse applications, chiefly in molecular genetics. The global transcriptomic market could see a whole lot of instances of new product launch. For example, Trio RNA-Seq launched by NuGEN Technologies, Inc. is particularly suited for low abundance transcripts applications as it offers an extremely sensitive whole transcriptomic solution. This innovation embodies three powerful technologies, viz. single primer isothermal amplification (SPIA), DimerFree, and AnyDeplete, for performing high sensitivity ribonucleic acid (RNA) analysis.

Highlights

The global Transcriptomics market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
North America is the largest consumption place, with a consumption market share nearly 55% . Following North America, Europe is the second largest consumption place with the consumption market share of 25% .The key manufacturers are Thermo Fisher Scientific, Illumina, QIAGEN (Exiqon), Agilent Technologies, Roche, GE Healthcare, Bio-Rad Laboratories, Fluidigm etc. Top 3 companies occupied about 41% market share.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Transcriptomics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transcriptomics.
The Transcriptomics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Transcriptomics market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transcriptomics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights


In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Thermo Fisher Scientific
Illumina
QIAGEN (Exiqon)
Agilent Technologies
Roche
GE Healthcare
Bio-Rad Laboratories
Fluidigm

Product Type Insights

Global markets are presented by Transcriptomics type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Transcriptomics are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Transcriptomics segment by Type

PCR
Microarray
Sequencing

Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Transcriptomics market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Transcriptomics market.
Transcriptomics Segment by Application

Pharmaceutical and Biotechnology
Academic Research and Government Institutes
Hospitals and Diagnostic Centers

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Transcriptomics market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transcriptomics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Transcriptomics and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Transcriptomics industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transcriptomics.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Transcriptomics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.

Frequently Asked Questions

What factors will challenge the Product Name market growth?
Which end-use segment will expand at the fastest CAGR in the Product Name market?
Which are the emerging players in the Product Name market?
How concentrated is the Product Name market?
Which factors are positively contributing to the Product Name market growth?
Which are the novel product innovations in the Product Name market?
Which product segment will emerge as the most lucrative in the Product Name market?
Which factors are increasing the competition in the Product Name market?
Which are the strategic measures taken by the Product Name industry players?
Which region will witness inactive growth during the forecast period?
What key trends are likely to emerge in the Product Name market in the coming years?


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Transcriptomics by Type
2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
1.2.2 PCR
1.2.3 Microarray
1.2.4 Sequencing
2.3 Transcriptomics by Application
2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029)
2.3.2 Pharmaceutical and Biotechnology
2.3.3 Academic Research and Government Institutes
2.3.4 Hospitals and Diagnostic Centers
2.4 Assumptions and Limitations
3 Transcriptomics Breakdown Data by Type
3.1 Global Transcriptomics Historic Market Size by Type (2018-2023)
3.2 Global Transcriptomics Forecasted Market Size by Type (2023-2028)
4 Transcriptomics Breakdown Data by Application
4.1 Global Transcriptomics Historic Market Size by Application (2018-2023)
4.2 Global Transcriptomics Forecasted Market Size by Application (2018-2023)
5 Global Growth Trends
5.1 Global Transcriptomics Market Perspective (2018-2029)
5.2 Global Transcriptomics Growth Trends by Region
5.2.1 Global Transcriptomics Market Size by Region: 2018 VS 2022 VS 2029
5.2.2 Transcriptomics Historic Market Size by Region (2018-2023)
5.2.3 Transcriptomics Forecasted Market Size by Region (2024-2029)
5.3 Transcriptomics Market Dynamics
5.3.1 Transcriptomics Industry Trends
5.3.2 Transcriptomics Market Drivers
5.3.3 Transcriptomics Market Challenges
5.3.4 Transcriptomics Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Transcriptomics Players by Revenue
6.1.1 Global Top Transcriptomics Players by Revenue (2018-2023)
6.1.2 Global Transcriptomics Revenue Market Share by Players (2018-2023)
6.2 Global Transcriptomics Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Transcriptomics Head office and Area Served
6.4 Global Transcriptomics Players, Product Type & Application
6.5 Global Transcriptomics Players, Date of Enter into This Industry
6.6 Global Transcriptomics Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Transcriptomics Market Size (2018-2029)
7.2 North America Transcriptomics Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Transcriptomics Market Size by Country (2018-2023)
7.4 North America Transcriptomics Market Size by Country (2024-2029)
7.5 United States
7.6 Canada
8 Europe
8.1 Europe Transcriptomics Market Size (2018-2029)
8.2 Europe Transcriptomics Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Transcriptomics Market Size by Country (2018-2023)
8.4 Europe Transcriptomics Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Transcriptomics Market Size (2018-2029)
9.2 Asia-Pacific Transcriptomics Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Transcriptomics Market Size by Country (2018-2023)
9.4 Asia-Pacific Transcriptomics Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 Latin America
10.1 Latin America Transcriptomics Market Size (2018-2029)
10.2 Latin America Transcriptomics Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Transcriptomics Market Size by Country (2018-2023)
10.4 Latin America Transcriptomics Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Transcriptomics Market Size (2018-2029)
11.2 Middle East & Africa Transcriptomics Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Transcriptomics Market Size by Country (2018-2023)
11.4 Middle East & Africa Transcriptomics Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 Players Profiled
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Transcriptomics Introduction
11.1.4 Thermo Fisher Scientific Revenue in Transcriptomics Business (2017-2022)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Illumina
11.2.1 Illumina Company Detail
11.2.2 Illumina Business Overview
11.2.3 Illumina Transcriptomics Introduction
11.2.4 Illumina Revenue in Transcriptomics Business (2017-2022)
11.2.5 Illumina Recent Development
11.3 QIAGEN (Exiqon)
11.3.1 QIAGEN (Exiqon) Company Detail
11.3.2 QIAGEN (Exiqon) Business Overview
11.3.3 QIAGEN (Exiqon) Transcriptomics Introduction
11.3.4 QIAGEN (Exiqon) Revenue in Transcriptomics Business (2017-2022)
11.3.5 QIAGEN (Exiqon) Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Detail
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies Transcriptomics Introduction
11.4.4 Agilent Technologies Revenue in Transcriptomics Business (2017-2022)
11.4.5 Agilent Technologies Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Transcriptomics Introduction
11.5.4 Roche Revenue in Transcriptomics Business (2017-2022)
11.5.5 Roche Recent Development
11.6 GE Healthcare
11.6.1 GE Healthcare Company Detail
11.6.2 GE Healthcare Business Overview
11.6.3 GE Healthcare Transcriptomics Introduction
11.6.4 GE Healthcare Revenue in Transcriptomics Business (2017-2022)
11.6.5 GE Healthcare Recent Development
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Detail
11.7.2 Bio-Rad Laboratories Business Overview
11.7.3 Bio-Rad Laboratories Transcriptomics Introduction
11.7.4 Bio-Rad Laboratories Revenue in Transcriptomics Business (2017-2022)
11.7.5 Bio-Rad Laboratories Recent Development
11.8 Fluidigm
11.8.1 Fluidigm Company Detail
11.8.2 Fluidigm Business Overview
11.8.3 Fluidigm Transcriptomics Introduction
11.8.4 Fluidigm Revenue in Transcriptomics Business (2017-2022)
11.8.5 Fluidigm Recent Development
13 Report Conclusion
14 Disclaimer
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Transcriptomics Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Transcriptomics Revenue Market Share by Type (2018-2023)
Table 7. Global Transcriptomics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Transcriptomics Revenue Market Share by Type (2024-2029)
Table 9. Global Transcriptomics Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Transcriptomics Revenue Market Share by Application (2018-2023)
Table 11. Global Transcriptomics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Transcriptomics Revenue Market Share by Application (2024-2029)
Table 13. Global Transcriptomics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Transcriptomics Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Transcriptomics Market Share by Region (2018-2023)
Table 16. Global Transcriptomics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Transcriptomics Market Share by Region (2024-2029)
Table 18. Transcriptomics Market Trends
Table 19. Transcriptomics Market Drivers
Table 20. Transcriptomics Market Challenges
Table 21. Transcriptomics Market Restraints
Table 22. Global Top Transcriptomics Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Transcriptomics Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Transcriptomics Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Transcriptomics, Headquarters and Area Served
Table 26. Global Transcriptomics Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Transcriptomics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Transcriptomics Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Transcriptomics Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Transcriptomics Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Transcriptomics Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Transcriptomics Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Transcriptomics Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Transcriptomics Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Transcriptomics Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Transcriptomics Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Transcriptomics Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Transcriptomics Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Transcriptomics Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Transcriptomics Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Transcriptomics Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Transcriptomics Market Size by Country (2024-2029) & (US$ Million)
Table 45. Thermo Fisher Scientific Company Detail
Table 46. Thermo Fisher Scientific Business Overview
Table 47. Thermo Fisher Scientific Transcriptomics Product
Table 48. Thermo Fisher Scientific Revenue in Transcriptomics Business (2017-2022) & (US$ Million)
Table 49. Thermo Fisher Scientific Recent Development
Table 50. Illumina Company Detail
Table 51. Illumina Business Overview
Table 52. Illumina Transcriptomics Product
Table 53. Illumina Revenue in Transcriptomics Business (2017-2022) & (US$ Million)
Table 54. Illumina Recent Development
Table 55. QIAGEN (Exiqon) Company Detail
Table 56. QIAGEN (Exiqon) Business Overview
Table 57. QIAGEN (Exiqon) Transcriptomics Product
Table 58. QIAGEN (Exiqon) Revenue in Transcriptomics Business (2017-2022) & (US$ Million)
Table 59. QIAGEN (Exiqon) Recent Development
Table 60. Agilent Technologies Company Detail
Table 61. Agilent Technologies Business Overview
Table 62. Agilent Technologies Transcriptomics Product
Table 63. Agilent Technologies Revenue in Transcriptomics Business (2017-2022) & (US$ Million)
Table 64. Agilent Technologies Recent Development
Table 65. Roche Company Detail
Table 66. Roche Business Overview
Table 67. Roche Transcriptomics Product
Table 68. Roche Revenue in Transcriptomics Business (2017-2022) & (US$ Million)
Table 69. Roche Recent Development
Table 70. GE Healthcare Company Detail
Table 71. GE Healthcare Business Overview
Table 72. GE Healthcare Transcriptomics Product
Table 73. GE Healthcare Revenue in Transcriptomics Business (2017-2022) & (US$ Million)
Table 74. GE Healthcare Recent Development
Table 75. Bio-Rad Laboratories Company Detail
Table 76. Bio-Rad Laboratories Business Overview
Table 77. Bio-Rad Laboratories Transcriptomics Product
Table 78. Bio-Rad Laboratories Revenue in Transcriptomics Business (2017-2022) & (US$ Million)
Table 79. Bio-Rad Laboratories Recent Development
Table 80. Fluidigm Company Detail
Table 81. Fluidigm Business Overview
Table 82. Fluidigm Transcriptomics Product
Table 83. Fluidigm Revenue in Transcriptomics Business (2017-2022) & (US$ Million)
Table 84. Fluidigm Recent Development
Table 85. Thermo Fisher Scientific Company Information
Table 86. Thermo Fisher Scientific Business Overview
Table 87. Thermo Fisher Scientific Transcriptomics Revenue in Transcriptomics Business (2018-2023) & (US$ Million)
Table 88. Thermo Fisher Scientific Revenue in Transcriptomics Business (2018-2023) & (US$ Million) Portfolio
Table 89. Thermo Fisher Scientific Recent Development
Table 90. Illumina Company Information
Table 91. Illumina Business Overview
Table 92. Illumina Transcriptomics Revenue in Transcriptomics Business (2018-2023) & (US$ Million)
Table 93. Illumina Revenue in Transcriptomics Business (2018-2023) & (US$ Million) Portfolio
Table 94. Illumina Recent Development
Table 95. QIAGEN (Exiqon) Company Information
Table 96. QIAGEN (Exiqon) Business Overview
Table 97. QIAGEN (Exiqon) Transcriptomics Revenue in Transcriptomics Business (2018-2023) & (US$ Million)
Table 98. QIAGEN (Exiqon) Revenue in Transcriptomics Business (2018-2023) & (US$ Million) Portfolio
Table 99. QIAGEN (Exiqon) Recent Development
Table 100. Agilent Technologies Company Information
Table 101. Agilent Technologies Business Overview
Table 102. Agilent Technologies Transcriptomics Revenue in Transcriptomics Business (2018-2023) & (US$ Million)
Table 103. Agilent Technologies Revenue in Transcriptomics Business (2018-2023) & (US$ Million) Portfolio
Table 104. Agilent Technologies Recent Development
Table 105. Roche Company Information
Table 106. Roche Business Overview
Table 107. Roche Transcriptomics Revenue in Transcriptomics Business (2018-2023) & (US$ Million)
Table 108. Roche Revenue in Transcriptomics Business (2018-2023) & (US$ Million) Portfolio
Table 109. Roche Recent Development
Table 110. GE Healthcare Company Information
Table 111. GE Healthcare Business Overview
Table 112. GE Healthcare Transcriptomics Revenue in Transcriptomics Business (2018-2023) & (US$ Million)
Table 113. GE Healthcare Revenue in Transcriptomics Business (2018-2023) & (US$ Million) Portfolio
Table 114. GE Healthcare Recent Development
Table 115. Bio-Rad Laboratories Company Information
Table 116. Bio-Rad Laboratories Business Overview
Table 117. Bio-Rad Laboratories Transcriptomics Revenue in Transcriptomics Business (2018-2023) & (US$ Million)
Table 118. Bio-Rad Laboratories Revenue in Transcriptomics Business (2018-2023) & (US$ Million) Portfolio
Table 119. Bio-Rad Laboratories Recent Development
Table 120. Fluidigm Company Information
Table 121. Fluidigm Business Overview
Table 122. Fluidigm Transcriptomics Revenue in Transcriptomics Business (2018-2023) & (US$ Million)
Table 123. Fluidigm Revenue in Transcriptomics Business (2018-2023) & (US$ Million) Portfolio
Table 124. Fluidigm Recent Development
Table 125. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Transcriptomics Product Picture
Figure 5. Global Transcriptomics Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Transcriptomics Market Share by Type: 2022 VS 2029
Figure 7. PCR Product Picture
Figure 8. Microarray Product Picture
Figure 9. Sequencing Product Picture
Figure 10. Global Transcriptomics Market Size by Application (2023-2029) & (US$ Million)
Figure 11. Global Transcriptomics Market Share by Application: 2022 VS 2029
Figure 12. Pharmaceutical and Biotechnology Product Picture
Figure 13. Academic Research and Government Institutes Product Picture
Figure 14. Hospitals and Diagnostic Centers Product Picture
Figure 15. Global Transcriptomics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Transcriptomics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Transcriptomics Market Share by Region: 2022 VS 2029
Figure 18. Global Transcriptomics Market Share by Players in 2022
Figure 19. Global Transcriptomics Players, Date of Enter into This Industry
Figure 20. Global Top 5 and 10 Transcriptomics Players Market Share by Revenue in 2022
Figure 21. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 22. North America Transcriptomics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. North America Transcriptomics Market Share by Country (2018-2029)
Figure 24. United States Transcriptomics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Canada Transcriptomics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Transcriptomics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Transcriptomics Market Share by Country (2018-2029)
Figure 28. Germany Transcriptomics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Transcriptomics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Transcriptomics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Transcriptomics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Transcriptomics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Transcriptomics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Transcriptomics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Asia-Pacific Transcriptomics Market Share by Country (2018-2029)
Figure 36. China Transcriptomics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Japan Transcriptomics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. South Korea Transcriptomics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Southeast Asia Transcriptomics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. India Transcriptomics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Australia Transcriptomics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Transcriptomics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Latin America Transcriptomics Market Share by Country (2018-2029)
Figure 44. Mexico Transcriptomics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Brazil Transcriptomics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Transcriptomics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Transcriptomics Market Share by Country (2018-2029)
Figure 48. Turkey Transcriptomics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Saudi Arabia Transcriptomics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. UAE Transcriptomics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Transcriptomics Business (2018-2023)
Figure 52. Illumina Revenue Growth Rate in Transcriptomics Business (2018-2023)
Figure 53. QIAGEN (Exiqon) Revenue Growth Rate in Transcriptomics Business (2018-2023)
Figure 54. Agilent Technologies Revenue Growth Rate in Transcriptomics Business (2018-2023)
Figure 55. Roche Revenue Growth Rate in Transcriptomics Business (2018-2023)
Figure 56. GE Healthcare Revenue Growth Rate in Transcriptomics Business (2018-2023)
Figure 57. Bio-Rad Laboratories Revenue Growth Rate in Transcriptomics Business (2018-2023)
Figure 58. Fluidigm Revenue Growth Rate in Transcriptomics Business (2018-2023)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings